ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,883Medicare Part D Prescriptions Filled, Including Refills

Rank: 91 out of 1844

$648K Total Retail Price of All Prescriptions

Rank: 177 out of 1844

413 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 413 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

18% of this provider’s 413 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 10,485 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 672 544 1 1
LISINOPRIL 635 512 2 4
HYDROCODONE-ACETAMINOPHEN 491 338 S3 3 2
METFORMIN HCL ER 489 320 4 46
SIMVASTATIN 480 386 5 3
FUROSEMIDE 438 373 6 7
TRAMADOL HCL 397 289 7 18
CARVEDILOL 328 301 8 22
WARFARIN SODIUM 302 240 9 13
OMEPRAZOLE 291 216 10 5
METOPROLOL TARTRATE 263 217 11 11
GABAPENTIN 243 164 12 15
RANITIDINE HCL 229 190 13 38
ALLOPURINOL 219 182 14 29
POLYETHYLENE GLYCOL 3350 191 163 15 39
AZITHROMYCIN 188 151 16 37
METFORMIN HCL 187 130 17 8
BUSPIRONE HCL 186 108 18 127
SPIRONOLACTONE 181 160 19 60
ZOLPIDEM TARTRATE 172 126 20 23
OXYBUTYNIN CHLORIDE 169 141 21 103
LOSARTAN POTASSIUM 165 146 22 24
LOVAZA 157 85 23 138
LISINOPRIL-HYDROCHLOROTHIAZIDE 154 117 24 20
SERTRALINE HCL 149 113 25 21
LOVASTATIN 142 111 26 44
CIPROFLOXACIN HCL 138 111 27 62
MELOXICAM 120 97 28 28
CRESTOR 118 101 29 30
AMLODIPINE BESYLATE 118 113 29 6
LEVEMIR FLEXPEN 118 91 29 166
METOPROLOL SUCCINATE 116 100 32 14
GLIMEPIRIDE 115 87 33 35
KLOR-CON 10 113 79 34 123
NEXIUM 109 40 35 31
ATENOLOL 100 86 36 17
PAROXETINE HCL 98 80 37 68
POTASSIUM CHLORIDE 97 68 38 16
METHYLPREDNISOLONE 88 76 39 125
CITALOPRAM HBR 85 45 40 19
JANUVIA 85 56 40 77
DONEPEZIL HCL 85 81 40 26
TRIAMTERENE-HCTZ 82 69 43 48
KLOR-CON M20 79 74 44 54
TRIAMCINOLONE ACETONIDE 76 62 45 153
FENTANYL 75 75 S2 46 66
PROAIR HFA 74 36 47 45
CEFUROXIME 65 52 48 184
ALENDRONATE SODIUM 63 56 49 25
CLOPIDOGREL 62 51 50 34
AMITRIPTYLINE HCL 59 40 R 51 72
TORSEMIDE 56 44 52 118
TRAZODONE HCL 55 36 53 43
KLOR-CON M10 54 48 54 149
NAMENDA 51 38 55 33
PRAVASTATIN SODIUM 51 46 55 10
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 30, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.